Cargando…
The Multi-Dimensional Biomarker Landscape in Cancer Immunotherapy
The field of immuno-oncology is now at the forefront of cancer care and is rapidly evolving. The immune checkpoint blockade has been demonstrated to restore antitumor responses in several cancer types. However, durable responses can be observed only in a subset of patients, highlighting the importan...
Autores principales: | Lee, Jing Yi, Kannan, Bavani, Lim, Boon Yee, Li, Zhimei, Lim, Abner Herbert, Loh, Jui Wan, Ko, Tun Kiat, Ng, Cedric Chuan-Young, Chan, Jason Yongsheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9323480/ https://www.ncbi.nlm.nih.gov/pubmed/35887186 http://dx.doi.org/10.3390/ijms23147839 |
Ejemplares similares
-
Spatial transcriptomics reveal topological immune landscapes of Asian head and neck angiosarcoma
por: Loh, Jui Wan, et al.
Publicado: (2023) -
Classification of HER2-negative breast cancers by ERBB2 copy number alteration status reveals molecular differences associated with chromosome 17 gene aberrations
por: Loh, Jui Wan, et al.
Publicado: (2023) -
Multiregion sequencing of sarcomatoid renal cell carcinoma arising from autosomal dominant polycystic kidney disease
por: Lee, Elizabeth, et al.
Publicado: (2022) -
Checkpoint immunotherapy for NK/T cell lymphoma—Time for a showdown?
por: Chan, Jason Yongsheng, et al.
Publicado: (2021) -
Circulating Tumor DNA Mutations in Progressive Gastrointestinal Stromal Tumors Identify Biomarkers of Treatment Resistance and Uncover Potential Therapeutic Strategies
por: Ko, Tun Kiat, et al.
Publicado: (2022)